Endo Pharmaceuticals has Everybody Interested as M&A Target

By: Benzinga
Remember the days of youth when everybody wanted to hang out with you? To many friends, too little time was how your life worked as a high school and college student. Endo Pharmaceuticals (NASDAQ: ENDP ) likely feels that way. Shares of this healthcare stock vaulted more than 10
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.